An early stage protein therapeutics company has developed a novel AI-driven platform for rapid, iterative antibody design and characterization and is in the process of prioritizing applications of their platform for a set of initial Proof of Concept (POC) programs. To that end, the BCBA project team will 1) evaluate the current research and framework […]

A direct-to-consumer (DTC) diagnostics company is developing a blood test panel for the assessment of chronic inflammation. Using a cutting-edge AI-based platform, the company is optimizing a panel that can provide their customers with deep insights on their inflammatory status with only a few drops of blood. Given the massive increase in DTC and telemedicine […]

The multi-institutional project team will conduct a survey to evaluate and prioritize ocular indications for a venture-backed company’s novel gene editing platform.

Lupa Bio is a start-up company founded to advance evolutionary biology with an aim to disrupt the prescription anti-inflammatory market.  They are an innovative, Indie Bio-funded company with a founding team

The multi-institutional project team will analyze and prioritize oncology targets for drug development by an early stage, venture-backed company with an innovative medicinal chemistry platform

The multi-institutional project team will evaluate the drug discovery landscape to prioritize market entry points for a versatile human stem cell-based technology platform that can be used in preclinical testing